Evidence map›Paper›PMID 34267243›Full record

ArticleScientific reports2021

Spatio-temporal expression pattern and role of the tight junction protein MarvelD3 in pancreas development and function.

Charlotte Heymans, Ophélie Delcorte, Catherine Spourquet, Mylah Villacorte-Tabelin, Sébastien Dupasquier, Younes Achouri, Siam Mahibullah, Pascale Lemoine, Maria S Balda, Karl Matter and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. BRAFCancers · 2022
    Article
  8. BRAFBiomedicines · 2022
    Article
  9. Review
  10. High expression ofFrontiers in genetics · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Charlotte Heymans *Cell Biology Unit, de Duve Institute, UCLouvain, Woluwe, Belgium.
Ophélie Delcorte *Cell Biology Unit, de Duve Institute, UCLouvain, Woluwe, Belgium.
Catherine SpourquetCell Biology Unit, de Duve Institute, UCLouvain, Woluwe, Belgium.
Mylah Villacorte-TabelinCell Biology Unit, de Duve Institute, UCLouvain, Woluwe, Belgium.
Sébastien DupasquierCell Biology Unit, de Duve Institute, UCLouvain, Woluwe, Belgium.
Younes AchouriTransgenesis Platform, UCLouvain, Woluwe, Belgium.
Siam MahibullahCell Biology Unit, de Duve Institute, UCLouvain, Woluwe, Belgium.
Pascale LemoineCell Biology Unit, de Duve Institute, UCLouvain, Woluwe, Belgium.
Maria S BaldaInstitute of Ophthalmology, UCL, London, UK.
Karl MatterInstitute of Ophthalmology, UCL, London, UK.
Christophe E PierreuxCell Biology Unit, de Duve Institute, UCLouvain, Woluwe, Belgium. christophe.pierreux@uclouvain.be.

Funding

BBSRC BB/J015032/1
6 · The paper itself

Abstract

Tight junction complexes are involved in the establishment and maintenance of cell polarity and the regulation of signalling pathways, controlling biological processes such as cell differentiation and cell proliferation. MarvelD3 is a tight junction protein expressed in adult epithelial and endothelial cells. In Xenopus laevis, MarvelD3 morphants present differentiation defects of several ectodermal derivatives. In vitro experiments further revealed that MarvelD3 couples tight junctions to the MEKK1-JNK pathway to regulate cell behaviour and survival. In this work, we found that MarvelD3 is expressed from early developmental stages in the exocrine and endocrine compartments of the pancreas, as well as in endothelial cells of this organ. We thoroughly characterized MarvelD3 expression pattern in developing pancreas and evaluated its function by genetic ablation. Surprisingly, inactivation of MarvelD3 in mice did not alter development and differentiation of the pancreatic tissue. Moreover, tight junction formation and organization, cell polarization, and activity of the JNK-pathway were not impacted by the deletion of MarvelD3.

Indexed as

AnimalsCell DifferentiationCRISPR-Cas SystemsFemaleGene Expression Regulation, DevelopmentalMaleMAP Kinase Signaling SystemMARVEL Domain-Containing ProteinsMiceMice, Inbred C57BLMice, KnockoutPancreasSalivary GlandsSpatio-Temporal AnalysisTight Junction ProteinsMARVEL Domain-Containing ProteinsTight Junction Proteins

Identifiers

PMID34267243
PMCPMC8282860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.